您好,欢迎来到上海士研管理咨询有限公司
产业峰会 演讲局 专家智库服务 峰会活动服务 整合营销服务
  • 产业峰会:
    以专业团队对产业和市场客观详实地调研为前提,拥有战略性、系统性、全球性的基因,汇集了领导者关注的热点话题与领袖代表,为您提供“一站式”的对话、分享、社交平台!
  • 演讲局:
    致力于为全球企业和机构提供主题演讲家、高管大师班、董事会顾问,每项服务都提供了一种更深入、更具互动性的体验,尤其是针对较小的精选受众和关键个人。我们拥有最具影响力的商业领袖和顶级专家的资源,他们是各自领域的最杰出的代表。我们的团队由经验丰富的演讲和活动经理组成,我们注重建立长期而深入的伙伴关系。
  • 专家智库服务:
    中国领先的行业专家知识信息服务供应商,为需要专业洞见的商业决策者匹配具有一手经验的行业专家,助力他们以更加明确的目标和坚定的信心做出决策。我们有60万余名专家顾问遍布二十多个行业,而且每天还在增加!
  • 峰会活动服务:
    致力于成为全球最专业的产业峰会活动提供商,为企业和机构的产业性峰会活动提供一站式专业服务,包括调研策划、定制邀请、营销推广、运营组织、项目管理、直播与数字化会议等,每项服务都由经验丰富的专业团队匹配长期沉淀的产业资源予以卓越执行,我们注重建立长期而深入的伙伴关系。
  • 整合营销服务:
    致力于成为全球领先的2B营销服务机构,聚焦产业高端活动、内容、渠道的建设与沉淀,为客户提供一站式整合营销解决方案,助力企业线上线下获客与品牌筑造。我们深信专业团队匹配产业资源带来卓越执行,我们注重建立长期而深入的伙伴关系。
会议赞助商
4
2023 - 08 - 23
点击次数:
泓博医药(股票代码:301230)成立于2007年,总部位于上海,致力于为全球医药客户提供新药研发和商业化生产一站式综合服务,涵盖药物发现、制药工艺的研究开发以及原料药、中间体的商业化生产等领域。目前,公司拥有超过22000平方米研发实验室(37000平方米临床前新药研发基地在建中)以及60000平方米生产基地,研发技术人员占比超63%。在16年的征途中,泓博医药通过特有的“CRO”和“CDMO业务模式,构建了全方位综合性技术平台,为国内外客户的新药研发提供了有力支撑。 PharmaResources(StockCode:301230.SZ)was founded in 2007 and is headquartered in Shanghai. The company is committed to providing comprehensive services for global pharmaceutical clients, including new drug research and development and commercial production, covering areas such as drug discovery, pharmaceutical process research and development, as well as commercial production of active pharmaceutical ingredients and intermediates. Currently, the company has over 22,000 square meters of R&D laboratories (with a 37,000 square meter preclinical new drug R&D base under construction) and a 60,000 square meter production base. R&D technical personnel account for over 63% of the workforce. Over the course of its 16-year journey, PharmaResources has established a comprehensive technical platform through its unique 'CRO' and 'CDMO' business models, providing strong support for the new drug development of domestic and international clients.
5
2023 - 08 - 23
点击次数:
药明康德(股票代码:603259.SH/2359.HK)为全球生物医药行业提供一体化、端到端的新药研发和生产服务,在亚洲、欧洲、北美等地均设有运营基地。药明康德通过独特的“CRDMO”和“CTDMO”业务模式,不断降低研发门槛,助力客户提升研发效率,为患者带来更多突破性的治疗方案,服务范围涵盖化学药研发和生产、生物学研究、临床前测试和临床试验研发、细胞及基因疗法研发、测试和生产等领域。2022年,药明康德被MSCI评为ESG(环境、社会及管治)AA级。目前,公司的赋能平台正承载着来自全球30多个国家的6000多家合作伙伴的研发创新项目,致力于将更多新药、好药带给全球病患,早日实现“让天下没有难做的药,难治的病”的愿景。As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the pharmaceutical and healthcare industry around the world to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, and cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received AA ESG rating from MSCI in 2022 and its open-access platform is enabling more than 6,000 customers from over 30 countries to improve the health of those in need – and to realize the vision that 'every drug can be made and every disease can be treated.'
6
2023 - 08 - 23
点击次数:
太仓市沿江临沪,地处沿海经济带和长三角经济圈核心位置,距离上海张江药谷和苏州BioBAY均只需1小时车程,高铁900秒抵达上海虹桥站,2027年地铁接轨上海。太仓港是长江外贸第一大港,位列全球集装箱港口第22位。太仓将生物医药作为重点发展的战略性新兴产业,围绕新药研发生产、医疗器械、医药服务外包等领域,已集聚了昭衍新药、康乃德生物、中美冠科、含光微纳、思纳福、赛业模式生物、依科赛生物等400余家生物医药企业,形成了完善的上下游产业链。Taicang is not only borders Shanghai but also faces the Yangtze River, located in the core position of the coastal economic belt and the Yangtze River Delta economic circle. It is only about an one-hour drive both from Shanghai Zhangjiang Pharmaceutical Valley and Suzhou BioBAY and 900 seconds from Taicang railway station to Shanghai Hongqiao railway station. In additon, the subway will be connected to Shanghai in 2027. Taicang port is the largest foreign trade port on the Yangtze River and the 22th in the global container ports. Taicang prioritized Biomedical as a strategic industry, with a focus on new medical development and production, medical devices, and pharmaceutical outsourcing services. The biomedical industry has gathered nearly 400 biomedical enterprises in the city, including Joinn Laboratories, Connect Biopharmaceuticals, Crown Bioscience, HiComp Microtech, Sinafu Medical Technology, Cyagen Biosciences, ExCell Biotech and other potential biomedical enterprises, Already formed a complete industrial chain.
微信公众号
领导者网络APP
友情链接
Copyright ©2005 - 2017上海士研管理咨询有限公司
犀牛云提供企业云服务